Mallorie Amy, Goldring James, Patel Anant, Lim Eric, Wagner Thomas
aDepartments Nuclear Medicine bDepartment of Respiratory Medicine, Royal Free London NHS Foundation Trust cRoyal Brompton & Harefield NHS Foundation Trust, London, UK.
Nucl Med Commun. 2017 Aug;38(8):715-719. doi: 10.1097/MNM.0000000000000703.
Lymph node involvement in non-small-cell lung cancer (NSCLC) is a major factor in determining management and prognosis. We aimed to evaluate the accuracy of fluorine-18-fluorodeoxyglucose-PET/computed tomography (CT) for the assessment of nodal involvement in patients with NSCLC.
In this retrospective study, we included 61 patients with suspected or confirmed resectable NSCLC over a 2-year period from April 2013 to April 2015. 221 nodes with pathological staging from surgery or endobronchial ultrasound-guided transbronchial needle aspiration were assessed using a nodal station-based analysis with original clinical reports and three different cut-offs: mediastinal blood pool (MBP), liver background and tumour standardized uptake value maximal (SUVmax)/2.
Using nodal station-based analysis for activity more than tumour SUVmax/2, the sensitivity was 45%, the specificity was 89% and the negative predictive value (NPV) was 87%. For activity more than MBP, the sensitivity was 93%, the specificity was 72% and NPV was 98%. For activity more than liver background, the sensitivity was 83%, the specificity was 84% and NPV was 96%. Using a nodal staging-based analysis for accuracy at detecting N2/3 disease, for activity more than tumour SUVmax/2, the sensitivity was 59%, the specificity was 85% and NPV was 80%. For activity more than MBP, the sensitivity was 95%, the specificity was 61% and NPV was 96%. For activity more than liver background, the sensitivity was 86%, the specificity was 81% and NPV was 92%. Receiver-operating characteristic analysis showed the optimal nodal SUVmax to be more than 6.4 with a sensitivity of 45% and a specificity of 95%, with an area under the curve of 0.85.
Activity more than MBP was the most sensitive cut-off with the highest sensitivity and NPV. Activity more than primary tumour SUVmax/2 was the most specific cut-off. Nodal SUVmax more than 6.4 has a high specificity of 95%.
非小细胞肺癌(NSCLC)中的淋巴结受累是决定治疗和预后的主要因素。我们旨在评估氟-18-氟脱氧葡萄糖-PET/计算机断层扫描(CT)在评估NSCLC患者淋巴结受累情况时的准确性。
在这项回顾性研究中,我们纳入了2013年4月至2015年4月这两年间61例疑似或确诊为可切除NSCLC的患者。对221个经手术或支气管内超声引导下经支气管针吸活检获得病理分期的淋巴结,采用基于淋巴结分区的分析方法,并结合原始临床报告以及三种不同的截断值进行评估:纵隔血池(MBP)、肝脏本底以及肿瘤标准化摄取值最大值(SUVmax)的一半。
采用基于淋巴结分区的分析方法,以高于肿瘤SUVmax/2作为活性标准时,敏感性为45%,特异性为89%,阴性预测值(NPV)为87%。以高于MBP作为活性标准时,敏感性为93%,特异性为72%,NPV为98%。以高于肝脏本底作为活性标准时,敏感性为83%,特异性为84%,NPV为96%。采用基于淋巴结分期的分析方法来检测N2/3期疾病的准确性时,以高于肿瘤SUVmax/2作为活性标准,敏感性为59%,特异性为85%,NPV为80%。以高于MBP作为活性标准时,敏感性为95%,特异性为61%,NPV为96%。以高于肝脏本底作为活性标准时,敏感性为86%,特异性为81%,NPV为92%。受试者工作特征分析显示,最佳淋巴结SUVmax大于6.4,敏感性为45%,特异性为95%,曲线下面积为0.85。
高于MBP的活性是最敏感的截断值,具有最高的敏感性和NPV。高于原发肿瘤SUVmax/2的活性是最具特异性的截断值。淋巴结SUVmax大于6.4具有95%的高特异性。